MET Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
19.2B
+0.4%
19.1B
-19.9%
23.8B
+37.2%
17.4B
+0.1%
17.3B
Cost of Revenue
11.3B
-4.5%
11.9B
-29.3%
16.8B
+61.8%
10.4B
-3.7%
10.8B
Gross Profit
7.8B
+8.4%
7.2B
+2.4%
7.0B
+0.7%
7.0B
+6.4%
6.6B
Operating Expenses
18.1B
+3.1%
17.6B
-21.9%
22.5B
+38.0%
16.3B
-0.3%
16.4B
R&D
SG&A
0
0
-100.0%
13.9B
0
0
Operating Income
1.0B
-30.7%
1.5B
+14.7%
1.3B
+23.9%
1.1B
+7.2%
980.0M
EBITDA
783.0M
-47.6%
1.5B
+437.2%
-443000000
-142.2%
1.1B
+48.4%
708.0M
Net Income
779.0M
-33.0%
1.2B
+42.4%
816.0M
-9.5%
902.0M
+22.7%
735.0M
EPS (Basic)
$1.10
-37.1%
$1.75
+48.3%
$1.18
-4.1%
$1.23
+18.3%
$1.04
EPS (Diluted)
$1.09
-37.4%
$1.74
+47.5%
$1.18
-3.3%
$1.22
+18.4%
$1.03
Shares (Diluted)
646.9M
-1.3%
655.7M
-1.0%
662.1M
-1.0%
669.1M
-0.9%
675.0M
MetLife (MET) — Financials